Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	9.88	9.99	13.01	17.8	7.16	16.6
Short-Term Investments	24.45	31.34	52.75	89.32	140.46	-
Cash & Short-Term Investments	34.33	41.34	65.76	107.12	147.62	16.6
Cash Growth	-40.89%	-37.14%	-38.61%	-27.44%	789.50%	6511.95%
Prepaid Expenses	0.91	0.47	1.17	1.13	0.55	1.38
Other Current Assets	0.44	0.12	0.33	0.34	0.37	2.11
Total Current Assets	35.68	41.93	67.25	108.59	148.54	20.08
Property, Plant & Equipment	2.57	3.38	7.04	9.72	4.64	1.27
Other Long-Term Assets	0.02	0.05	0.09	0.06	0.04	0.09
Total Assets	38.27	45.36	74.37	118.38	153.23	21.43
Accounts Payable	0.36	0.24	0.57	4.47	2.46	3.88
Accrued Expenses	2.63	2.73	2.41	2.46	1.75	0.92
Current Portion of Leases	2.15	2.32	2.44	2.13	0.68	0.03
Other Current Liabilities	0.09	0.16	0.22	-	-	-
Total Current Liabilities	5.23	5.45	5.64	9.07	4.89	4.83
Long-Term Debt	-	-	-	-	-	0.57
Long-Term Leases	1.06	1.53	3.77	5.9	1.67	0.09
Other Long-Term Liabilities	-	-	0.07	-	0.15	0.05
Total Liabilities	6.29	6.98	9.48	14.97	6.71	5.54
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	300.91	300.45	297	302.2	296.05	55.97
Retained Earnings	-268.92	-262.05	-231.9	-197.79	-149.21	-112.41
Comprehensive Income & Other	-0.01	-0.01	-0.21	-1	-0.33	-
Total Common Equity	31.99	38.39	64.9	103.41	146.51	-56.44
Shareholders' Equity	31.99	38.39	64.9	103.41	146.51	15.89
Total Liabilities & Equity	38.27	45.36	74.37	118.38	153.23	21.43
Total Debt	3.21	3.85	6.21	8.03	2.35	0.69
Net Cash (Debt)	31.12	37.49	59.55	99.08	145.27	15.91
Net Cash Growth	-40.65%	-37.04%	-39.90%	-31.79%	813.00%	-
Net Cash Per Share	24.75	29.85	42.61	64.54	104.85	197.39
Filing Date Shares Outstanding	1.26	1.26	1.25	1.55	1.53	1.53
Total Common Shares Outstanding	1.26	1.26	1.25	1.54	1.53	0.09
Working Capital	30.45	36.48	61.61	99.52	143.65	15.25
Book Value Per Share	25.38	30.49	51.85	67.23	95.73	-601.92
Tangible Book Value	31.99	38.39	64.9	103.41	146.51	-56.44
Tangible Book Value Per Share	25.38	30.49	51.85	67.23	95.73	-601.92
Machinery	0.35	1.66	2.64	3.24	5.58	1.86
Leasehold Improvements	0.25	0.25	0.25	0.25	0.25	-

Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q